The Precision Peptide Company Inc. (BPC)
CSE
0.3600
-0.03 (-7.69%)
Real-time Data
01:30 PM
Day's Range
0.35500.3950
52 wk Range
0.17500.5800
Financial Statements - BPC - The Precision Peptide Company Inc.
Revenue
49.72K▲ 307.5%
Net Income
-4.52M▼ 339.0%Net Margin -9104.3%
EBITDA
121.96K▲ 115.1%
Free Cash Flow
-2.33M▼ 431.1%
Income Statement
| Period Ending | 2025-10-31 | 2024-10-31 |
|---|---|---|
| Sales | 49.72K | 12.20K |
| Cost of Goods | 27.77K | 5.29K |
| Gross Profit | 21.94K | 6.90K |
 Operating Expense | - | - |
| Operating Income | -2.25M | -920.70K |
| Non-Operating Interest | - | - |
| Other Income Expense | -2.28M | -110.38K |
| Pre Tax Income | -4.52M | -1.03M |
| Income Tax | - | - |
| Net Income | -4.52M | -1.03M |
| EPS Basic | -0.21 | -0.15 |
| EPS Diluted | -0.21 | -0.15 |
| Basic Shares Outstanding | 21.65M | 6.68M |
| Diluted Shares Outstanding | 21.65M | 6.68M |
| Ebit | -2.25M | -920.70K |
| Ebitda | 121.96K | -806.82K |
| Net Income Continuous Operations | -4.52M | -1.03M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
